Results 31 to 40 of about 36,916 (167)

Characteristics and Patterns of Proton Pump Inhibitors Prescribing at the Primary Health Care

Medicina, 2022
Background and objectives: the aim of this study was to analyse the utilisation of proton pump inhibitors (PPIs) during a 12-year period and to show the characteristics and patterns of their prescribing.
Nataša Stojaković, Ana Golić Jelić, Svjetlana Stoisavljević Šatara, Nataša Bednarčuk, Miloš P. Stojiljković, Ranko Škrbić   +5 more
doaj   +1 more source

Effects of Ultrasound Treatment on Emulsifying Properties of Pea Protein Isolates Obtained from Four Different Pea Flour Varieties

Foods
This study investigated the extraction and colloidal properties of pea protein isolates (PPIs) from four pea cultivars produced in a southern region in Italy.
Fatma Dadi, Ahmed Taha, Lucas Sales Queiroz, Naaman Francisco Nogueira Silva, Ipek Altay, Yuri Kominami, Rodolphe Marie, Aberham Hailu Feyissa, Jens J. Sloth, Heidi Olander Petersen, Mauro Grandi, Giorgia Spigno, Federico Casanova   +12 more
doaj   +1 more source

Assessing the druggability of protein-protein interactions by a supervised machine-learning method

BMC Bioinformatics, 2009
Background Protein-protein interactions (PPIs) are challenging but attractive targets of small molecule drugs for therapeutic interventions of human diseases.
Ikeda Kazuyoshi, Sugaya Nobuyoshi
doaj   +1 more source

Community-dwelling older adults’ awareness of the inappropriate use of proton pump inhibitors

BMC Geriatrics, 2020
Background Proton pump inhibitors (PPIs) are effective in treating gastroesophageal reflux, peptic ulcers, and esophagitis. However, the long-term use of PPIs by older adults is associated with adverse health outcomes.
Mohammad Rababa, Abeer Rababa’h
doaj   +1 more source

Effect of long-term proton pump inhibitors on phosphocalcium metabolism and bone mineral density

Future Science OA
Aim: Although Proton pump inhibitors (PPIs) are well-tolerated, their long-term use may be associated with decreased bone mass. Methods: This is a case-control study including patients treated with PPIs (>1 year) and control subjects who have not ...
Hend Smaoui, Lassaad Chtourou, Dana Jallouli, Samar Ben Jemaa, Iheb Karaa, Mouna Boudabbous, Manel Moalla, Hela Gdoura, Leila Mnif, Ali Amouri, Rim Akrout, Fatma Ayadi, Sofien Baklouti, Nabil Tahri   +13 more
doaj   +1 more source

Assessment of vitamin B12 tissue stores in elderly proton pump inhibitor users

Cogent Medicine, 2017
Background: Adults over the age of 65 years are more prone to gastroesophageal reflux and, as such, are commonly prescribed proton pump inhibitors (PPIs). PPIs inhibit gastric acid secretion which can have adverse effects on vitamin B12 absorption.
Judith M. Lukaszuk, David A. Walker, Masih Shokrani, Josephine Umoren, Eric J. Norman   +4 more
doaj   +1 more source

Proton pump inhibitors may increase the risk of cisplatin-induced acute kidney injury in patients with nasopharyngeal carcinoma: a prospective cohort study

Scientific Reports
Cisplatin is the most commonly used platinum-based treatment for nasopharyngeal carcinoma (NPC). However, its clinical application is limited owing to its nephrotoxicity and gastrointestinal reactions.
Haiqing Luo, Guihua Yi, Haifeng Tang, Lingli Chen, Liren Hu, Donghong Yang, Zihong Chen, Haiwen Li, Dechao Zhan, Ying Yu, Ying Zeng, Yilin Cai, Jiayuan Wu, Huafeng Liu   +13 more
doaj   +1 more source

Protein-Protein Interactions in Candida albicans

Frontiers in Microbiology, 2019
Despite being one of the most important human fungal pathogens, Candida albicans has not been studied extensively at the level of protein-protein interactions (PPIs) and data on PPIs are not readily available in online databases.
Floris Schoeters, Floris Schoeters, Patrick Van Dijck, Patrick Van Dijck   +3 more
doaj   +1 more source

Oral Ppi VS IV Ppi in Hospitalized Patient

Journal of Gastroenterology & Digestive Systems, 2018
Objectives: Of this study have been produced in order to promote effective use of proton pump inhibitors (PPIs) and (H2RAs) histamine II receptor antagonists at AL-Zahraa University Hospital (ZUH) in Lebanon. The aims: Of the study are to ensure PPIs use is limited to situations where there is indicated and there is a clear evidence of benefit, in ...
openaire   +1 more source

Improving the feasibility of deprescribing proton pump inhibitors: GPs’ insights on barriers, facilitators, and strategies

Frontiers in Pharmacology
IntroductionThe prevalent overprescribing of proton pump inhibitors (PPIs) poses health risks from prolonged use. GPs play a key role in initiating deprescribing PPIs, so understanding their decision-making factors and strategies to improve feasibility ...
Nuša Japelj, Lea Knez, Lea Knez, Davorina Petek, Nejc Horvat   +4 more
doaj   +1 more source